TRACON Pharmaceuticals
San Diego, US · Delaware corporation · 11 employees on LinkedIn · 2 known investors
TRACON Pharmaceuticals was a biopharmaceutical company that is currently undergoing liquidation and dissolution as of November 2024.
Founders & leadership
HC
H CASEY LOGANExecutive
CP
CHARLES P. THEUERExecutive
PL
PATRICIA L. BITARExecutive
Board
PW
PAUL WALKERBoard director
SW
STEPHEN WORLANDBoard director
WL
WILLIAM LARUEBoard director
JR
J. RAINER TWIFORDBoard director
MM
MARTIN MATTINGLYBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$39.7M disclosed across 2 rounds · 2017–2018
▶$38.7MraisedApr 2018 · 11 investors · BiotechnologyRule 506(b)
▶$38.7MraisedApr 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J. RAINER TWIFORDDirector
- PAUL WALKERDirector
- TED WANGDirector
- WILLIAM LARUEDirector
- CHARLES P. THEUERExecutive Officer, Director
- PATRICIA L. BITARExecutive Officer
- STEPHEN WORLANDDirector
- MARTIN MATTINGLYDirector
- Offering amount
- $75.7M
- Amount sold
- $38.7M
- Sales commissions
- $2M
- Placement agents
- Angel Pond Capital LLC, LifeSci Capital
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedMay 2017 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedMay 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN WORLANDDirector
- WILLIAM LARUEDirector
- J. RAINER TWIFORDDirector
- H CASEY LOGANExecutive Officer
- CHARLES P. THEUERExecutive Officer, Director
- PATRICIA L. BITARExecutive Officer
- MARTIN MATTINGLYDirector
- PAUL WALKERDirector
- Offering amount
- $21M
- Amount sold
- $1M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does TRACON Pharmaceuticals do?
- TRACON Pharmaceuticals was a biopharmaceutical company that is currently undergoing liquidation and dissolution as of November 2024.
- Who are TRACON Pharmaceuticals's investors?
- TRACON Pharmaceuticals's investors include New Enterprise Associates (NEA), Runway Growth Capital.
- How much funding has TRACON Pharmaceuticals raised?
- TRACON Pharmaceuticals has disclosed $39.7M raised across 2 rounds.
- Where is TRACON Pharmaceuticals headquartered?
- TRACON Pharmaceuticals is headquartered in San Diego, US.